在评估心脏参与全身性硬化症的生物标志物
Mohamad Fadhli Bin Masri1, Sue-Ann Ng1,2, Calvin Wl Chin3
1Department of Rheumatology and Immunology, Singapore General Hospital, Bukit Merah, Singapore.
Rheumatology and immunology research
|July 17, 2024
概括
系统性硬化症可能会导致心脏损伤,心脏特罗波宁和IL-6等生物标志物有助于早期检测. 在全身性硬化症中识别这些心脏生物标志物可以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 系统性硬化症是一种多系统性自身免疫性疾病,具有显著的心脏参与,影响高达80%的患者.
- 系统性硬化症中的心脏并发症导致死亡率增加.
- 早期识别心脏干扰对于管理患者的结果至关重要.
研究的目的:
- 审查目前用于诊断,预后和预测系统性硬化症中初级心脏参与的生物标志物.
- 探索基于系统性硬化症病理生理学的新生物标志物.
- 强调生物标志物的临床实用性,用于早期检测和改善患者管理.
主要方法:
- 对系统性硬化症中心脏参与的诊断和预后生物标志物的文献综述.
- 对源自心脏损伤 (例如,热素) 和免疫失调 (例如,IL-6) 的生物标志物的分析.
- 鉴定潜在的新生物标志物,根据当前的疾病理解.
主要成果:
- 心脏特罗波宁和像IL-6这样的促炎细胞因子是已知的生物标志物.
- 生物标志物可以表明直接的心脏损伤或反映潜在的免疫过程.
- 无症状患者可能具有可通过生物标志物检测到的高风险心脏干扰.
结论:
- 生物标志物对于早期识别心脏参与系统性硬化症至关重要,包括无症状个体.
- 利用这些生物标志物可以带来及时的干预和更好的患者预后.
- 对新型生物标志物的进一步研究有望改善系统性硬化症中心脏并发症的管理.
更多相关视频
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
16.7K
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.3K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
133
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
133
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
73
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
73